INS and obesity disorder: This is an important feature as, ω-3 PUFAs can improve impaired metabolism in obesity by modulating main metabolic pathways [47], such as promoting anti-inflammatory response or insulin sensitivity [48], regulating the adipocyte apoptosis [49], or modulating membrane fluidity by altering lipid rafts [50].